D L Carlson Investment Group Inc. Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

D L Carlson Investment Group Inc. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,421 shares of the medical equipment provider's stock after selling 544 shares during the period. Intuitive Surgical accounts for about 1.4% of D L Carlson Investment Group Inc.'s investment portfolio, making the stock its 15th biggest holding. D L Carlson Investment Group Inc.'s holdings in Intuitive Surgical were worth $8,049,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the fourth quarter valued at $28,000. Summit Securities Group LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $30,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $31,000. Institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Stifel Nicolaus upped their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a report on Thursday, December 5th. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Finally, Piper Sandler reissued an "overweight" rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $611.86.

Remove Ads

Intuitive Surgical Stock Down 6.1 %

Shares of Intuitive Surgical stock traded down $30.03 during mid-day trading on Friday, hitting $464.58. The stock had a trading volume of 1,662,324 shares, compared to its average volume of 1,533,414. The firm has a 50-day moving average of $547.83 and a two-hundred day moving average of $532.58. The firm has a market cap of $165.48 billion, a P/E ratio of 72.22, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,754 shares of company stock worth $17,691,621. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.